Synthesis and anticalcium activity of new compounds containing the 2,3- dihydro-1,4-dioxino[2,3-b]pyridine system

Scientia Pharmaceutica

Volumn 68, Issue 2, 2000, Pages 159-164

  Sanchez I ^a   Pujol, M D ^a   Guillaumet, G ^b   Massingham, R ^c   Monteil, A ^d   Dureng, G ^d   Winslow, E ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c UCB PHARMA   (Belgium)

^d CERM Centre Europeen de Recherches Mauvernay   (France)

Author keywords

1,4 benzodioxin; 1,4 dioxino 2,3 b pyridine; Anticalcium activity

Indexed keywords

3 [N BIS(4 FLUOROPHENYL)METHOXYETHYL N METHYLAMINOMETHYL] 2,3 DIHYDRO 1,4 DIOXINO[2,3 B]PYRIDINE; 3 [N BIS(4 FLUOROPHENYL)METHOXYETHYLAMINOMETHYL] 2,3 DIHYDRO 1,4 DIOXINO[2,3 B]PYRIDINE; CALCIUM ANTAGONIST; DILTIAZEM; FLUNARIZINE; NIFEDIPINE; UNCLASSIFIED DRUG; VERAPAMIL;

ALKYLATION; ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE;

EID: 0034733590     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.aut-00-14     Document Type: Article

References (9)

1. Janis R. A., Triggle D. J. (1983), J. Med. Chem. 26 : 777.
2. Mannhold R. (1988), Recent advances in receptor chemistry, Elsevier Science Publishers B. V. 147.
3. Bourlot A. S., Sánchez I., Dureng G., Guillaument G., Massingham R., Monteil A., Winslow E., Pujol M. D., Mérour J.Y. (1998), J. Med. Chem. 41 : 3142.
4. Sánchez I., PuJol M. D., Guillaumet G., Massingham R., Monteil A., Dureng G., Winslow E. (2000), Eur. J. Med. Chem. Accepted in press.
5. Benarab A., Poirot P., Guillaumet G. (1993), Heterocycles 36 : 1598.
6. Benoît J., Benarab A., Guillaumet G. (1994), Heterocycles 38 : 1355.
7. Benarab A., Comoy C., Guillaumet G. (1994), Heterocycles 38 : 1641.
8. Winslow E., Farmer S., Martorana M., Marshall R. J. (1986), Eur. J. Pharmacol. 131 : 219.
9. John G. W., Fàbregues E., Kamal M., Massingham R. (1991), Eur. J. Pharmacol. 196 : 307.